...
首页> 外文期刊>Japanese Journal of Pharmacology >Novel Benzodioxan Derivative, 5-{ 3- [((2S)-1, 4-Benzodioxan-2-ylmethyl)amino] propoxy} -1, 3-benzodioxole HC1 (MKC-242), with a Highly Potent and Selective Agonist Activity at Rat Central SerotoninlA Receptors
【24h】

Novel Benzodioxan Derivative, 5-{ 3- [((2S)-1, 4-Benzodioxan-2-ylmethyl)amino] propoxy} -1, 3-benzodioxole HC1 (MKC-242), with a Highly Potent and Selective Agonist Activity at Rat Central SerotoninlA Receptors

机译:新型苯并二恶英衍生物5- {3- [(((2S)-1,4-Benzodioxan-2-ylmethyl)amino] propoxy} -1,3-benzodioxole HC1(MKC-242),具有强力和选择性激动剂活性。在大鼠中央5-羟色胺受体上

获取原文

摘要

References(55) Cited-By(36) The present study characterizes the neurochemical profile of the newly synthesized compound 5-{3-[((2S)-1, 4-benzodioxan-2-ylmethyl)amino]propoxy}-1, 3-benzodioxole HC1 (MKC-242). In in vitro experiments, MKC-242 had high affinity for serotonin1A (5-HT1A) receptors (K1: 0.35 nM) and moderate affinity for α1-adrenoceptors (Ki: 21 nM), whereas it had no appreciable affinity for any other neurotrans-mitter recognition sites studied and 5-HT transporter. MKC-242 (0.3-3.0 mg/kg, s.c.; 1-10 mg/kg, p.o.) caused presynaptic 5-HT1A-receptor-mediated responses (decreases in 5-HT turnover and 5-HT release) and postsynaptic 5-HT1A-receptor-mediated responses (hypothermia, an increase in serum corticosterone level and 5-HT1A behavioral syndrome). The effects of MKC-242 on decarboxylase inhibitor-induced 5-hydroxytryptophan accumulation and rectal temperature were blocked by the 5-HT1A-receptor antagonist N-tert-butyl-3-(4-(2-methoxyphenyl)piperazin-1-yl)-2-phenylpropanamide. The comparative studies on the in vivo responses induced by MKC-242 and the 5-HT1A-receptor full agonist 8-hydroxy-2-(di-n-propyl-amino)tetralin (8-OH-DPAT) showed that MKC-242 and 8-OH-DPAT had similar efficacy at presynaptic 5-HT1A receptors, whereas the former had less efficacy than the latter at postsynaptic 5-HT1A receptors. Furthermore, MKC-242 partially inhibited forskolin-stimulated adenylate cyclase activity in hippocampal membranes. These findings suggest that MKC-242 acts as a full and partial agonist at pre- and postsynaptic 5-HT1A receptors, respectively, in the central nervous system.
机译:参考文献(55)被By(36)引用本研究描述了新合成的化合物5- {3-[(((2S)-1,4-benzodioxan-2-ylmethyl)amino] propoxy} -1,的神经化学特征。 3-苯并二恶唑HCl(MKC-242)。在体外实验中,MKC-242对5-羟色胺1A(5-HT1A)受体具有高亲和力(K1:0.35 nM),对α1-肾上腺素受体具有中等亲和力(Ki:21 nM),而对任何其他神经反式研究了细菌识别位点和5-HT转运蛋白。 MKC-242(0.3-3.0 mg / kg,sc; 1-10 mg / kg,po)引起突触前5-HT1A受体介导的反应(5-HT周转率和5-HT释放降低)和突触后5-HT1A受体介导的反应(体温过低,血清皮质酮水平升高和5-HT1A行为综合征)。 5-HT1A-受体拮抗剂N-叔丁基-3-(4-(2-甲氧基苯基)哌嗪-1-基)阻断了MKC-242对脱羧酶抑制剂诱导的5-羟色氨酸积累和直肠温度的影响。 -2-苯基丙酰胺。对MKC-242和5-HT1A受体完全激动剂8-羟基-2-(二-正丙基-氨基)四氢化萘(8-OH-DPAT)诱导的体内反应的比较研究表明,MKC-242和8-OH-DPAT对突触前5-HT1A受体的疗效相似,而前者对突触后5-HT1A受体的疗效较后者差。此外,MKC-242部分抑制海马膜中福司柯林刺激的腺苷酸环化酶活性。这些发现表明,MKC-242在中枢神经系统中分别对突触前和突触后5-HT1A受体起全部和部分激动剂的作用。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号